Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant trastuzumab in women with HER2-positive primary breast cancer after adjuvant chemotherapy
2005-005274-71Phase 3Terminated
- Sponsor
- Innovative Sensor Technology IST AG
- Start
- Jan 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of trastuzumab in breast cancer, sponsored by Innovative Sensor Technology IST AG. Started Jan 2006; status: terminated.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2005-005274-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005274-71.